secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2023-10-05T23:59:59+00:00
Accession:  0001013762-23-002005
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics forms wholly-owned subsidiary merveille.ai for AI-driven drug discovery in rare diseases
--------------------------------------------------------------------------------

- Filed Articles of Incorporation in Nevada for merveille.ai on October 4, 2023.
- Subsidiary focuses on drug discovery for rare diseases using artificial intelligence.
- merveille.ai is a wholly-owned subsidiary of Hoth Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000101376223002005/0001013762-23-002005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000101376223002005/ea186346-8k_hoththera.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-002005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer